X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Newspaper Article (190897) 190897
Journal Article (19321) 19321
Magazine Article (8141) 8141
Trade Publication Article (7230) 7230
Web Resource (6557) 6557
Report (2004) 2004
Book Chapter (410) 410
Transcript (297) 297
Newsletter (259) 259
Government Document (206) 206
Book Review (111) 111
Conference Proceeding (15) 15
Book / eBook (13) 13
Dissertation (13) 13
Publication (6) 6
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
fda approval (233450) 233450
pharmaceutical industry (56886) 56886
clinical trials (40960) 40960
patients (25996) 25996
regulatory approval (21894) 21894
drug dosages (19024) 19024
research & development--r&d (18345) 18345
earnings per share (16837) 16837
stockholders (16711) 16711
prescription drugs (16409) 16409
cancer therapies (16328) 16328
covid-19 (16258) 16258
coronaviruses (15056) 15056
investments (14406) 14406
medical equipment (13949) 13949
product development (13833) 13833
net losses (12749) 12749
biotechnology industry (12590) 12590
studies (12557) 12557
pharmaceuticals (12542) 12542
science & technology (11262) 11262
stock exchanges (10953) 10953
medical research (10673) 10673
cancer (10620) 10620
life sciences & biomedicine (10206) 10206
corporate profits (10171) 10171
metastasis (10001) 10001
oncology (9846) 9846
drugs (9773) 9773
diabetes (9142) 9142
vaccines (9020) 9020
webcasting (8997) 8997
manufacturing (8570) 8570
financial performance (8499) 8499
collaboration (8475) 8475
disease (8398) 8398
marketing (8398) 8398
chemotherapy (8341) 8341
pain (8107) 8107
acquisitions & mergers (8057) 8057
tumors (7959) 7959
business metrics (7563) 7563
pediatrics (7170) 7170
drug therapy (7130) 7130
generic drugs (6908) 6908
laboratories (6881) 6881
humans (6834) 6834
infections (6716) 6716
chief executive officers (6570) 6570
medicine (6419) 6419
womens health (6365) 6365
breast cancer (6268) 6268
agreements (6218) 6218
hospitals (6044) 6044
narcotics (5953) 5953
appointments & personnel changes (5778) 5778
food (5699) 5699
pandemics (5540) 5540
mutation (5407) 5407
research (5197) 5197
immunotherapy (5173) 5173
archives & records (5136) 5136
proteins (5104) 5104
candidates (5075) 5075
lymphomas (5022) 5022
public health (4999) 4999
researchers (4951) 4951
drug approval (4913) 4913
lung cancer (4859) 4859
present value (4767) 4767
transplants & implants (4659) 4659
leukemia (4565) 4565
administrative expenses (4471) 4471
surgery (4463) 4463
biological products (4375) 4375
sales (4369) 4369
litigation (4270) 4270
intellectual property (4167) 4167
profit margins (4023) 4023
care and treatment (3894) 3894
capital losses (3890) 3890
cardiovascular disease (3886) 3886
antibiotics (3877) 3877
corporate profiles (3776) 3776
web sites (3761) 3761
commercialization (3753) 3753
equity (3736) 3736
proprietary (3669) 3669
medical technology (3636) 3636
hepatitis (3594) 3594
stem cells (3491) 3491
physicians (3471) 3471
alzheimers disease (3397) 3397
capital gains (3342) 3342
federal regulation (3342) 3342
short sales (3248) 3248
melanoma (3217) 3217
mortality (3172) 3172
gene therapy (3171) 3171
infectious diseases (3146) 3146
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Gerstein Science - Stacks (4) 4
Robarts - Stacks (2) 2
UofT at Mississauga - Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (234613) 234613
French (265) 265
Spanish (250) 250
German (246) 246
Italian (66) 66
Chinese (45) 45
Portuguese (19) 19
Hindi (9) 9
Turkish (9) 9
Urdu (7) 7
Japanese (6) 6
Dutch (2) 2
Norwegian (2) 2
Czech (1) 1
Korean (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2010, Princeton studies in American politics, ISBN 0691141800, xx, 802
The U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield... 
Pharmaceutical policy | Drugs | United States. Food and Drug Administration | United States | Research | History | Political Science | Health Sciences | Public Policy | POLITICAL SCIENCE | HISTORY | Food and Drug Administration
Book
The New England journal of medicine, ISSN 1533-4406, 08/2014, Volume 371, Issue 8, pp. 689 - 691
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 01/2018, Volume 78, Issue 1, pp. 139 - 145
...))) for the treatment of various haematological and solid malignancies. The drug has received accelerated approval from the US FDA for the treatment of mantle cell lymphoma based... 
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Protein-Tyrosine Kinases - metabolism | United States | Humans | Pyrazines - administration & dosage | Antineoplastic Agents - therapeutic use | Drug Approval | Pyrazines - therapeutic use | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Dose-Response Relationship, Drug | Benzamides - administration & dosage | Benzamides - therapeutic use | Antineoplastic Agents - adverse effects | Adult | Antineoplastic Agents - pharmacology | Benzamides - pharmacology | United States Food and Drug Administration | Antibodies, Monoclonal, Humanized - therapeutic use | Lymphoma, Mantle-Cell - drug therapy | Treatment Outcome | Protein Kinase Inhibitors - administration & dosage | Protein Kinase Inhibitors - therapeutic use | Agammaglobulinaemia Tyrosine Kinase | Protein Kinase Inhibitors - pharmacology | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Pyrazines - pharmacology | Protein-Tyrosine Kinases - antagonists & inhibitors | Tyrosine | Plasma | Regulatory agencies | Phosphorylation | Chronic lymphatic leukemia | Hematology | Leukemia | Metastasis | FDA approval | Kinases | Cancer therapies | Lymphoma | Bruton's tyrosine kinase | Mantle cell lymphoma | Response rates | Lymphomas | Mantle | Drug dosages | Protein-tyrosine kinase | Pharmaceuticals
Journal Article
Drugs (New York, N.Y.), ISSN 0012-6667, 2018, Volume 78, Issue 17, pp. 1829 - 1834
...Drugs (2018) 78:1829–1834 https://doi.org/10.1007/s40265-018-1004-5 ADISINSIGHT REPORT Fremanezumab: First Global Approval Sheridan M. Hoy 1 Published online... 
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Headache | Enzymes | Peptides | Migraine | Headaches | Neuropeptides | FDA approval | Regulatory approval | Studies | Prevention | Calcitonin gene-related peptide | Pain | Calcitonin | Response rates | Monoclonal antibodies | Clusters | Adults | Agreements | Pharmaceuticals
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 376, Issue 21, pp. 2001 - 2004
Journal Article
Journal Article
The New England journal of medicine, ISSN 0028-4793, 2014, Volume 370, Issue 26, pp. e39 - e39
This interactive graphic shows major legislative and regulatory events related to approval of new drugs by the Food and Drug Administration (FDA... 
Drug Discovery - history | History, 21st Century | United States | History, 20th Century | Humans | Drug Approval - history | Prescription Drugs - history | United States Food and Drug Administration - history | Drug development | FDA approval | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article